Publications by authors named "S Hayoz"

Claim this Profile
F
First-line immunotherapy ± chemotherapy with or without upfront stereotactic radiotherapy (SRT) in patients with Non-Small cell lung cancer (NSCLC) with asymptomatic brain metastases.
Lorenz Frehner, Sämi Schär, Stefanie Hayoz, Verena Petermichl, Philip Speicher

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-canonical Taste Transduction of Sugars Elicits Responses in a Dedicated Subset of Gustatory Afferent Neurons.
Yuryanni Rodriguez, Sebastien Hayoz, Gennady Dvoryanchikov, Stephen D Roper, Nirupa Chaudhari

J Neurosci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).
K-L Koster, I Colombo, S Hayoz, K Eckhardt, A Rojas Mora

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14.
L Frehner, S Schär, S Hayoz, M Guckenberger, T Finazzi

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16).
Marian Klose, Ilaria Colombo, Katrin Gobat, Kira-Lee Koster, Simon Haefliger, Stefanie Hayoz

Clin Pharmacokinet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis